Avalo Therapeutics at Stifel 2026 Healthcare Conference: phase iii ahead

🌐 Investing.com (Cyprus) —
Avalo Therapeutics at Stifel 2026 Healthcare Conference: phase iii ahead

AI Summary

Avalo Therapeutics is scheduled to present at the Stifel 2026 Healthcare Conference, with the headline highlighting progress toward Phase III. The article description provides no additional details about the company's clinical program or conference remarks.

Markets Health Avalo Therapeutics Stifel healthcare conference Phase III clinical development biotechnology

Read original source →